• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Stem cell transplantation for polycythemia vera.

作者信息

Reinhard Harald, Klingebiel Thomas, Lang Peter, Bader Peter, Niethammer Dietrich, Graf Norbert

机构信息

Pediatric Hematology and Oncology, University Hospital, Homburg/Saar, Germany.

出版信息

Pediatr Blood Cancer. 2008 Jan;50(1):124-6. doi: 10.1002/pbc.20906.

DOI:10.1002/pbc.20906
PMID:16724311
Abstract

Polycythemia vera (PV) is a rare disease in children. A 9-year-old male was diagnosed following laboratory results acquired because of an acute appendicitis. Regular phlebotomy was performed for over 2 years followed by alpha-interferon treatment. At the age of 12 years, HLA-matched unrelated stem cell transplantation including T-cell depletion was done. The conditioning regimen consisted of busulfan, cyclophosphamide, and ATG. Chimerism was monitored during the whole post-transplant period. A single dose of donor T-lymphocytes was given at month 3. One year after transplantation, chimerism was complete. The patient is in complete remission and shows no signs of transplant-related morbidity at month 78.

摘要

相似文献

1
Stem cell transplantation for polycythemia vera.
Pediatr Blood Cancer. 2008 Jan;50(1):124-6. doi: 10.1002/pbc.20906.
2
Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.改良预处理方案白消安-环磷酰胺序贯异基因干细胞移植治疗多发性骨髓瘤患者
Chin Med J (Engl). 2007 Mar 20;120(6):463-8.
3
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
4
Successful treatment with reduced-intensity stem cell transplantation for secondary myelofibrosis following polycythemia vera.真性红细胞增多症继发骨髓纤维化采用减低强度干细胞移植治疗成功。
Rinsho Ketsueki. 2009 Nov;50(11):1630-4.
5
Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).威斯科特-奥尔德里奇综合征的异基因造血干细胞移植:西班牙儿童血液与骨髓移植工作组(GETMON)报告
Pediatr Hematol Oncol. 2007 Sep;24(6):393-402. doi: 10.1080/08880010701454404.
6
Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.干细胞移植后威斯科特-奥尔德里奇综合征患者的预后:日本57例患者的分析
Br J Haematol. 2006 Nov;135(3):362-6. doi: 10.1111/j.1365-2141.2006.06297.x.
7
Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome.在针对施瓦茨曼-戴蒙德综合征儿童和青少年的预处理方案中,用氟达拉滨、曲奥舒凡和美法仑替代环磷酰胺和白消安。
Bone Marrow Transplant. 2007 Feb;39(3):143-7. doi: 10.1038/sj.bmt.1705553. Epub 2007 Jan 8.
8
Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.在异基因移植治疗血液系统恶性肿瘤前使用低剂量全身照射的减低强度预处理方案:来自欧洲血液和骨髓移植组的经验。
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):544-51. doi: 10.1016/j.ijrobp.2006.08.049. Epub 2006 Dec 4.
9
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.采用全身照射和粒细胞集落刺激因子联合大剂量阿糖胞苷预处理方案的异基因造血干细胞移植治疗初发急性髓性白血病的长期随访
Biol Blood Marrow Transplant. 2008 Jun;14(6):651-7. doi: 10.1016/j.bbmt.2008.03.006.
10
Diagnosis and therapy of polycythemia vera.真性红细胞增多症的诊断与治疗
Semin Thromb Hemost. 2006 Apr;32(3):267-75. doi: 10.1055/s-2006-939438.

引用本文的文献

1
Pediatric Philadelphia-Negative Myeloproliferative Neoplasms in the Era of WHO Classification: A Systematic Review.世界卫生组织分类时代的儿童费城阴性骨髓增殖性肿瘤:一项系统综述
Diagnostics (Basel). 2023 Jan 19;13(3):377. doi: 10.3390/diagnostics13030377.
2
Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome.鲁索替尼治疗一名患有JAK2阳性真性红细胞增多症相关布加综合征的婴儿。
BMJ Case Rep. 2017 Jul 14;2017:bcr-2017-220377. doi: 10.1136/bcr-2017-220377.
3
Myeloproliferative Neoplasms in Children.
儿童骨髓增殖性肿瘤
J Hematop. 2015 Sep;8(3):143-157. doi: 10.1007/s12308-015-0256-1. Epub 2015 Aug 2.
4
Clinical and hematological presentation of children and adolescents with polycythemia vera.真性红细胞增多症患儿及青少年的临床和血液学表现
Ann Hematol. 2009 Aug;88(8):713-9. doi: 10.1007/s00277-009-0758-y. Epub 2009 May 26.
5
Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera.真性红细胞增多症儿童和青少年前瞻性队列的临床及分子特征分析
Br J Haematol. 2008 Aug;142(4):622-6. doi: 10.1111/j.1365-2141.2008.07220.x. Epub 2008 Jun 28.